Font Size


The Cleanroom Alternative to CAR T-Cell Therapy and Regenerative Medicine Facilities

The Evolution of Regenerative Medicine

The evolution of regenerative medicine has sharpened
the focus on a chronic need for reproducibility, reliability
and contamination-free performance of basic laboratory
equipment essential to the process. Whether for research or
clinical applications, the need to tailor a suite of laboratory
equipment and instrumentation required for regenerative
medicine and CAR T-cell therapy involves an examination of
existing facility capabilities, funding sources, oversight and
compliance attributes, and throughput required for economic
benefit. This application note features insight into the progression of cellular therapy research and treatments.

Download the Application Note

TwinGuard ULT Freezer

About PHC Corporation of North America
PHC Corporation of North America is a subsidiary of PHC Holdings Corporation, Tokyo, Japan, a global leader in development, design and manufacturing of laboratory equipment for biopharmaceutical, life sciences, academic, healthcare and government markets. For more information, call PHC Corporation of North America at 800-858-8442, email or visit
©2019 PHC Corporation of North America

Font Size